Important dates:

  • Abstract submission1 December 2016
  • Standard registration19 January 2017


A plethora of genetic, dietary and pharmacological interventions can extend healthy lifespan in laboratory animals, and can delay or ameliorate diverse aging-related diseases. Many of the signalling pathways involved are evolutionarily conserved, and are starting to be implicated in human aging. This raises the intriguing possibility of performing preventative medicine against the chronic diseases of our time by targeting the main risk factor for all of them, namely aging. Two important current challenges in the field are (1) to understand the downstream pathways by which longevity interventions combat age-related loss of function and pathology, and (2) to translate the findings into the extension of human healthspan. 

Key Sessions

  1. Epigenetics
  2. Stem Cells
  3. Cell Signalling
  4. Translating Research to Benefit Aging Humans

Confirmed Plenary Speakers

Steve Horvath (UCLA David Geffen School of Medicine)
Sara Wickstr�m (Max Planck Institute for Biology of Ageing, Cologne)
Matt Kaeberlein (University of Washington)
Andrew Pospisilik (Max Planck Institute of Immunobiology and Epigenetics)
Eline Slagboom (Leids Universitair Medisch Centrum)
Adam Antebi (Max Planck Institute for Biology of Ageing)
Pinchas Cohen (USC Leonard Davis School of Gerontology)
Anne Brunet (Stanford School of Medicine)
Heinrich Jasper (Buck Institute for Research on Aging)

Confirmed Invited Speakers

Rozalyn Anderson (Memorial Veterans Hospital)
Changhan David Lee (University of Southern California)
Weiwei Dang (Huffington Center On Aging)
Eric Greer (Boston Children's Hospital)
Holly Brown-Borg (University of North Dakota)
Julie Mattison (Translational Gerontology Branch)
Emmanuelle Passegu� (University of California at San Francisco)
Malene Hansen (Sanford Burnham Prebys Medical)
Susana Gonzalo (Saint Louis University School of Medicine)
William Mair (Harvard University)
Scott Pletcher (University of Michigan)
Jackie Han (Chinese Academy of Sciences)
David Sinclair (Harvard Medical School)
Dana Miller (University of Washington)
Nick Musi (University of Texas Health Science Center)
Christiaan Leeuwenburgh (University of Florida)

Target Audience

This interdisciplinary meeting will address the above two challenges in depth, with participation from basic scientists, physicians and pharmacology experts. 

Related Events